| __timestamp | Amphastar Pharmaceuticals, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 14683100000 |
| Thursday, January 1, 2015 | 77347000 | 14921500000 |
| Friday, January 1, 2016 | 104189000 | 15567200000 |
| Sunday, January 1, 2017 | 90795000 | 16801100000 |
| Monday, January 1, 2018 | 106985000 | 16811600000 |
| Tuesday, January 1, 2019 | 131923000 | 17598300000 |
| Wednesday, January 1, 2020 | 143340000 | 19056500000 |
| Friday, January 1, 2021 | 199739000 | 21005600000 |
| Saturday, January 1, 2022 | 248860000 | 21911600000 |
| Sunday, January 1, 2023 | 351121000 | 27041900000 |
| Monday, January 1, 2024 | 36624400001 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis compares the gross profit trajectories of two industry players: Eli Lilly and Company and Amphastar Pharmaceuticals, Inc., from 2014 to 2023. Over this period, Eli Lilly's gross profit surged by approximately 84%, reaching its peak in 2023. This growth reflects the company's robust market strategies and successful product lines. In contrast, Amphastar Pharmaceuticals, while smaller in scale, demonstrated a remarkable 585% increase in gross profit, highlighting its aggressive expansion and market penetration strategies.
Eli Lilly consistently outperformed Amphastar, with gross profits averaging around 100 times higher. However, Amphastar's rapid growth rate suggests a promising future. These insights underscore the dynamic nature of the pharmaceutical sector, where both established giants and emerging players can thrive.
Gross Profit Analysis: Comparing Eli Lilly and Company and Pfizer Inc.
Gross Profit Analysis: Comparing Eli Lilly and Company and AstraZeneca PLC
Gross Profit Comparison: Eli Lilly and Company and Biogen Inc. Trends
Who Generates Higher Gross Profit? Eli Lilly and Company or Dr. Reddy's Laboratories Limited
Key Insights on Gross Profit: Eli Lilly and Company vs Bio-Techne Corporation
Cost Insights: Breaking Down Eli Lilly and Company and Amphastar Pharmaceuticals, Inc.'s Expenses
Who Generates Higher Gross Profit? Novo Nordisk A/S or Amphastar Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Sanofi and Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Alnylam Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? MorphoSys AG or Amphastar Pharmaceuticals, Inc.